Immune Netw.  2011 Feb;11(1):59-67. 10.4110/in.2011.11.1.59.

Dietary Aloe Improves Insulin Sensitivity via the Suppression of Obesity-induced Inflammation in Obese Mice

• Shin E
• Shim KS
• Kong H
• Lee S
• Shin S
• Kwon J
• Jo TH
• Park YI
• Lee CK
• Kim K

• KMID: 2150693
• DOI: http://doi.org/10.4110/in.2011.11.1.59

Abstract

BACKGROUND
Insulin resistance is an integral feature of metabolic syndromes, including obesity, hyperglycemia, and hyperlipidemia. In this study, we evaluated whether the aloe component could reduce obesity-induced inflammation and the occurrence of metabolic disorders such as blood glucose and insulin resistance.
METHODS
Male C57BL/6 obese mice fed a high-fat diet for 54 days received a supplement of aloe formula (PAG, ALS, Aloe QDM, and Aloe QDM complex) or pioglitazone (PGZ) and were compared with unsupplemented controls (high-fat diet; HFD) or mice fed a regular diet (RD). RT-PCR and western blot analysis were used to quantify the expression of obesity-induced inflammation.
RESULTS
Aloe QDM lowered fasting blood glucose and plasma insulin compared with HFD. Obesity-induced inflammatory cytokine (IL-1beta, -6, -12, TNF-alpha) and chemokine (CX3CL1, CCL5) mRNA and protein were decreased markedly, as was macrophage infiltration and hepatic triglycerides by Aloe QDM. At the same time, Aloe QDM decreased the mRNA and protein of PPARgamma/LXRalpha and 11beta-HSD1 both in the liver and WAT.
CONCLUSION
Dietary aloe formula reduces obesity-induced glucose tolerance not only by suppressing inflammatory responses but also by inducing anti-inflammatory cytokines in the WAT and liver, both of which are important peripheral tissues affecting insulin resistance. The effect of Aloe QDM complex in the WAT and liver are related to its dual action on PPARgamma and 11beta-HSD1 expression and its use as a nutritional intervention against T2D and obesity-related inflammation is suggested.

Keyword

Aloe QDM complex; Type 2 diabetes mellitus; Obesity-induced inflammation; Insulin sensitivity

MeSH Terms

11-beta-Hydroxysteroid Dehydrogenase Type 1
Aloe
Animals
Blood Glucose
Blotting, Western
Cytokines
Diabetes Mellitus, Type 2
Diet
Diet, High-Fat
Fasting
Glucose
Humans
Hyperglycemia
Hyperlipidemias
Inflammation
Insulin
Insulin Resistance
Liver
Macrophages
Male
Mice
Mice, Obese
Obesity
Plasma
PPAR gamma
RNA, Messenger
Thiazolidinediones
Triglycerides
11-beta-Hydroxysteroid Dehydrogenase Type 1
Blood Glucose
Cytokines
Glucose
Insulin
PPAR gamma
RNA, Messenger
Thiazolidinediones
Triglycerides

Figure

• 

  Figure 1 Effects of aloe formulas on body weight change and obesity-induced glucose intolerance. C57BL/6 mice were fed a high-fat diet supplemented with an aloe formula. (A) Weekly changes in body weight of aloe formula-supplemented mice. (B) fasting glucose and (C) insulin levels in plasma. Data are means±SEM.values. ‡p<0.01 compared with RD-fed mice. *p<0.05, †p<0.01 compared with untreated HFD-fed mice.

• 

  Figure 2 Histological observations of liver and WAT. At the end of the experimental period, (A) fatty livers were isolated from representative mice from each group, sectioned, and then stained with hematoxylin and eosin. Photomicrographs are of tissues isolated from RD-fed mice (a), untreated HFD mice (b), PGZ (c), PAG (d), ALS (e), Aloe QDM (f), and Aloe QDM complex-treated HFD mice (g). Photomicrographs were taken at a magnification of ×200. (B) epididymal fat pads were isolated from mice, sectioned, and then stained with hematoxylin and eosin. Photomicrographs are of tissues isolated from RD-fed mice (a), untreated HFD mice (b), PGZ (c), and Aloe QDM complex-treated HFD mice (d). Arrows show infiltrated cells. Photomicrographs were taken at a magnification of ×400.

• 

  Figure 3 Effect of aloe formulas on obesity-induced inflammation. Liver and WAT were isolated from mice. (A) mRNA expression in the both liver and WAT were measured by RT-PCR. (B) protein expression of inflammatory cytokine-related enzymes and (C) proinflammatory cytokines and chemokines were measured by western blot. This was repeated in triplicate and similar results were obtained in all three.

• 

  Figure 4 Effect of aloe formulas on adipogenesis. Liver and WAT were isolated from mice. (A) mRNA expression of PPARγ and LXRα in the both liver and WAT were measured by RT-PCR. (B) protein expression of ABCA1 was measured by western blot. (C) mRNA expression and (D) protein expression of 11β-HSD1 in both the liver and WAT were measured by RT-PCR and western blot, respectively. This was repeated in triplicate and similar results were obtained in all three.

• 

  Figure 5 Effects of aloe formulas on antiinflammatory cytokines. WAT were isolated from mice. Protein expressions of antiinflammatory cytokines were measured by western blot. This was repeated in triplicate and similar results were obtained in all three.

Reference

1. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998. 41:1241–1248.

2. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care. 2002. 5:551–559.

3. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003. 112:1821–1830.

4. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003. 112:1796–1808.

5. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997. 389:610–614.

6. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004. 114:147–152.

7. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001. 409:307–312.

8. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005. 436:356–362.

9. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010. 72:219–246.

10. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004. 24:29–33.

11. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. The biology of white adipocyte proliferation. Obes Rev. 2001. 2:239–254.

12. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993. 259:87–91.

13. Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol. 2008. 216:3–13.

14. Josep BR, Amir G, Jennifer K, Raquel H. Peroxisome proliferator-activated receptors: the nutritionally controlled molecular networks that integrate inflammation, immunity and metabolism. Curr Nutr Food Sci. 2005. 1:179–187.

15. Capasso F, Borrelli F, Capasso R, Di Carlo G, Izzo A, Pinto L, Mascolo N, Castaldo S, Longo R. Aloe and its therapeutic use. Phytother Res. 1998. 12:S124–S127.

16. Heggers JP, Kucukcelebi A, Stabenau CJ, Ko F, Broemeling LD, Robson MC, Winters WD. Wound healing effects of Aloe gel and other topical antibacterial agents on rat skin. Phytother Res. 1995. 9:455–457.

17. Koo MWL. Aloe vera: Antiulcer and antidiabetic effects. Phytother Res. 1994. 8:461–464.

18. Winters WD, Benavides R, Clouse WJ. Effects of aloe extracts on human normal and tumor cells in vitro. Econ Bot. 1981. 35:89–95.

19. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice: I. Clinical trial in new cases of diabetes mellitus. Phytomedicine. 1996. 3:241–243.

20. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine. 1996. 3:245–248.

21. Schwarz K, Mertz W. Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys. 1959. 85:292–295.

22. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998. 17:548–555.

23. Kim K, Kim H, Kwon J, Lee S, Kong H, Im SA, Lee YH, Lee YR, Oh ST, Jo TH, Park YI, Lee CK, Kim K. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine. 2009. 16:856–863.

24. Kong H, Lee S, Shin S, Kwon J, Jo TH, Shin E, Shim KS, Park YI, Lee CK, Kim K. Down-regulation of adipogenesis and hyperglycemia in diet-induced obesity mouse model by Aloe QDM. Biomolecules Therapeutics. 2010. 18:336–342.

25. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, Subramanian V, Mukundan L, Ferrante AW, Chawla A. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 2008. 7:496–507.

26. Kim J, Temple KA, Jones SA, Meredith KN, Basko JL, Brady MJ. Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels. J Biol Chem. 2007. 282:11038–11046.

27. Kim JO, Kim KS, Lee GD, Kwon JH. Antihyperglycemic and antioxidative effects of new herbal formula in streptozotocin-induced diabetic rats. J Med Food. 2009. 12:728–735.

28. Stienstra R, Mandard S, Tan NS, Wahli W, Trautwein C, Richardson TA, Lichtenauer-Kaligis E, Kersten S, Müller M. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver. J Hepatol. 2007. 46:869–877.

29. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem. 2000. 275:28240–28245.